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Abstract
Human papilloma virus (HPV) is a common virus that can cause genital warts and certain cancers. 
The HPV vaccine is effective in preventing many HPV-associated diseases, however, vaccination 
rates suggest many remain unprotected. This study examined successful strategies used by 
physicians to improve HPV vaccination rates.
Providers with above average vaccination rates were identified. A representative from each 
provider participated in an interview to identify strategies used to boost HPV vaccination.
Key strategies in ensuring vaccine completion were reminders, education, standing orders, and 
scheduling future vaccine appointments at time of first dose. Other successful strategies included 
coupling the HPV vaccine with adolescent vaccines, administering during well-visits, and 
recommending the vaccine as protection against cancer and genital warts.
Findings suggest successful and widely used methods among high performing providers in 
Louisiana, the majority of which should be easily reproducible with minimal resources to improve 
HPV vaccination rates.
INTRODUCTION
Human papillomavirus (HPV) is a common virus that has been shown to cause genital warts, 
as well as anogenital and oropharyngeal cancers.1 In fact, HPV is estimated to cause close to 
27,000 cancers each year in the U.S.1 and an average of 1,429 cancers annually in 
Louisiana.2,3 Most cervical cancers are caused by HPV, but so are a majority of the cancers 
of the vagina, vulva, penis, anus, and throat.
The first HPV vaccine was approved by the Food and Drug Administration over a decade 
ago, and the various iterations of the vaccine have been shown to be effective in preventing 
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cervical cancer and other HPV-associated cancers and genital warts. Vaccines are available 
for males and females ages 9–26, however, the federal Advisory Committee on 
Immunization Practices (ACIP) has recommended routine vaccination for male and female 
adolescents ages 11–12.4
Under the Affordable Care Act, most health plans must cover a defined set of preventive 
services with no cost-sharing by the patient, including HPV vaccination for children from 
age 11–21. The included health plans are Medicaid, the plans in the insurance marketplace, 
most small and large group plans, and most employer self-insured plans. While some plans 
existing before 2010 were grandfathered in and not required to provide the preventive 
services with no cost-sharing, the percentage of plans falling into this category is decreasing, 
and, over time, most plans will lose this status.5
Despite evidence that the vaccine is effective in reducing infection and its coverage by most 
insurances, rates remain below the Health People 2020 recommendation of 80%,6,7 
suggesting that many in the U.S. remain unprotected. The 2015 National Immunization 
Survey (NIS) results for completing all three shots in the HPV series for females was 39.3% 
and for males was 30.5% in Louisiana,7 both of which are significantly lower than the 
Healthy People 2020 target of 80% vaccination coverage. In October 2016, the Centers for 
Disease Control and Prevention changed its recommendations to a two shot series for 
adolescents under 15.8 While this should ease some of the barriers associated with series 
completion, with only 60.3% of females and 49.5% of males initiating the series in 
Louisiana in 2015, there is still a great deal of room for improvement.9
Previous research examined various methods used to increase vaccine uptake.10–14 These 
strategies range from educating both the providers and parents/adolescents to system 
changes, such as implementing standing orders or a reminder recall system. The study by 
Cassidy et al. supports the benefit of provider recommendation; 78.3% of parents mentioned 
that a recommendation from the providers aided in their decision to vaccinate. This study, as 
well as others, illustrate the benefit of patient reminders.10–14 Other studies have found that 
shot records helped to improve vaccination rates.11,14
In examining vaccination providers in Louisiana, it was obvious that some providers were 
having better HPV vaccination outcomes compared to other providers in the state 
(unpublished data). So what strategies are pediatricians and other healthcare providers in 
Louisiana using to increase the HPV vaccination rate and how can these strategies be used in 
any practice? The intent of this study was to discover uncommon but successful strategies 
providers can implement in their practices at little to no cost to increase initiation and 
completion of the vaccine series.
METHODS
This study sought to identify uncommon but successful behaviors that lead to better 
outcomes in HPV vaccination. The purpose was to identify best practices used by top 
performers. This qualitative study was conducted by the Louisiana Cancer Prevention and 
Control Program (LCP) with assistance from the Louisiana Department of Health Office of 
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Public Health Immunization Office. The Immunization Office identified providers with 
above average HPV vaccination rates based on total volume of vaccine administered 
compared to all providers in Louisiana. The volume of vaccine administered was determined 
by utilization of the immunization information system, Louisiana Immunization Network for 
Kids Statewide (LINKS), for inventory management. Three high-volume providers were 
identified in each of the nine public health regions in the state. Additional inclusion criteria 
were: 1) the key informant had to be 18 years or older, 2) be a healthcare provider or clinic 
director/administrator, and 3) providers must participate in Louisiana’s childhood 
immunization program and be English speaking. As a result, 28 providers were identified as 
having above average vaccine uptake. Of the 28 providers, 25 were pediatric clinics. The 
three remaining clinics offered services across age ranges. This study was approved by the 
Institutional Review Board.
The selected providers were contacted via letter from the Louisiana Immunization Office to 
explain the study and were asked if they agreed to be contacted by LCP. Contact information 
was then given to LCP to conduct key informant interviews.
Structured interviews were conducted with a representative from each of the twelve 
providers who participated in the study. The interviews were conducted using an interview 
guide developed by LCP to explore strategies providers used to increase HPV vaccine 
uptake. The interview guide included questions to elicit information on provider 
demographics and strategies used to increase HPV vaccination. General topics assessed were 
provider policies and procedures, provider-parent interaction, and provider strategies to 
increase HPV vaccination. Interviews were conducted over the phone and recorded with 
participant permission.
Statistical Analysis
Interviews were recorded for transcription and analyzed using NVivo11 qualitative analysis 
software. Interviews were linked with providers’ demographic data in NVivo. Each 
interview was independently coded. This was an iterative process. After completion of the 
independent coding, the authors came together to reviews the codes and identify common 
themes (Table 1). Differences were resolved through consensus.
RESULTS
Twelve of the 28 providers agreed to participate in the study. The 16 providers that did not 
participate either did not return calls to schedule an interview, chose not to participate, or a 
representative was not able to answer interview questions. The participants came from seven 
of the nine public health regions of the state and seven of the 64 parishes in the state. The 
sample consisted of providers whose patient populations were entirely or partially children, 
ages 0–18. Six providers had a patient population of 100% children. The remaining 
providers had patient populations of at least 85% children. The majority (79%) of the patient 
populations of the participating providers had family incomes below 200% of the federal 
poverty level.
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Themes identified through the analysis are shown in Table 1. The interviews showed that 
high-performing providers used a variety of strategies to get parents and youth/adolescents 
to initiate and complete the three-dose HPV vaccine series: education, standing orders, 
reminders, and scheduling vaccine appointments during current appointment. Other 
successful strategies included coupling the HPV vaccine with adolescent vaccines, 
administering during well visits, recommending the vaccine, and indicating that the HPV 
vaccine protects against cancer (Figure 1).
These researchers discovered that examining shot records helped providers stay abreast of 
patients that were eligible for the vaccine. As a result, patients and parents were able to 
receive education about the vaccine or the vaccine itself at well child visits or other doctor 
appointments.
The most frequently used strategies (Figure 1) were education (n=11) and standing orders 
(n=11), followed by reminders (n=10) and scheduling appointments for doses two and three 
during the current visit (n=8). Other strategies that were used moderately often include: 
offering the HPV vaccine with the other adolescent vaccines (n=6), indicating that the 
vaccine can protect against cancer (n=6), recommending the vaccine to patients (n=6), and 
offering the vaccine during well visits (n=6). The least frequent strategy reported by 
providers was informing parents that their insurance may cover the cost of the vaccine, 
thereby removing cost as a barrier (n=1) and only two providers indicated discussing the 
association of HPV infection with sexual activity.
Specific provider comments regarding strategies to increase HPV vaccination rates are 
detailed in Table 2.
DISCUSSION
Studies have shown that a physician recommendation may be the most important factor in 
HPV vaccination adherence,15,16 and according to Reiter, et al., vaccine initiation is higher 
among parents who receive such recommendations.17 At least one study has found that 
pediatricians and family physicians are reluctant to recommend the vaccine because of the 
perceived necessity to discuss sexual activity in children.18 However, one systematic review 
found that only 6–12% of parents indicated a concern that the vaccine would promote sexual 
activity across the studies reviewed.16 Another study, a systematic review of European 
studies, found that parents of children who had received prior vaccines had higher rates of 
acceptance of the HPV vaccine in all 23 studies reviewed.19 Along with these studies, our 
findings support the idea that physicians may be more successful by including the vaccine in 
their general recommendations for vaccines and limiting such discussion only to those 
families who ask. In fact, the CDC suggests recommending the HPV vaccine in the same 
way that other child and adolescent vaccines are offered, that is without lengthy discussions 
on transmission.20
Many physicians miss the opportunity to recommend and administer the vaccine at crucial 
11 or 12-year wellness visits.21 This study discovered several approaches to reducing these 
missed opportunities. This includes having standing orders for HPV vaccination and making 
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that recommendation at every visit, well or sick. Other successful providers simply included 
the vaccine in the list of recommendations for the 11 or 12-year well visit. Combining both 
approaches should significantly decrease missed opportunities.
The findings of this study included the use of reminder calls and text messages and 
scheduling appointments for subsequent doses at the time of the first dose to increase 
adherence to series completion. While moving to a two-dose series should facilitate 
completion, further investigation is warranted on systems changes including alternative 
hours and sites for vaccination to overcome the barriers to completing the series.
While insurance coverage was not mentioned frequently by those interviewed, informing 
parents about their coverage could reduce hesitancy related to financial burdens. According 
to the 2015 Louisiana Health Insurance Survey, 59.6% of children in Louisiana are covered 
by Medicaid, which covers vaccination at no cost to parents.22 Of children in Louisiana, in 
2016 less than 4% had no health insurance and less than 7.5% and dropping were covered by 
grandfathered plans and could be expected to have out of pocket expenses for vaccination.23 
This leave approximately 90% of children in Louisiana fully covered for HPV vaccination.
There are some limitations to this study. The sample size is small and involves clinics with a 
large population of patients under 200% FPL and covered by Medicaid. Therefore, the same 
strategies may not be applicable to providers with patients who are above the federal poverty 
level, are largely covered by private insurance, have significantly smaller or larger patient 
populations or are located in rural or suburban area.
The practices are summarized in Figure 2. The next steps in this process will be to design 
ways to allow other providers to practice these behaviors and monitor the effectiveness of 
such practices. To that end, the Louisiana Immunization Work Group has been formed with 
the mission of improving immunization rates through coordinated activities and sharing of 
information. The partnership includes the Louisiana Department of Health Immunization 
Program, medical society chapters including the Louisiana Chapter of the American 
Academy of Pediatrics, cancer programs such as the American Cancer Society and the 
Louisiana Cancer Prevention and Control Programs, immunization partners, health systems, 
and insurance partners.
CONCLUSION
This study uncovered successful and widely used methods among high performing providers 
in Louisiana. The majority of these strategies require simple system changes within the 
practice that should be easily reproducible to improve HPV vaccination rates. Further, these 
practices require minimal resources and most if not all can easily be implemented in any 
practice. Collaborative efforts are underway in Louisiana to disseminate these and other 
practices.
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Figure 1. 
Strategies used by providers to increase vaccination rates
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Figure 2. 
Seven Way to Improve HPV Vaccination Rates
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Table 1
Common themes
Themes Child Codes
Appointment Patient given appointment for vaccination during current visit
Education • Cards
• Drug Rep
• Handouts
• Informational Posters
• Nursing Staff
• Pictures
• Talking
• Tape (video)
Insurance Insurance is seen as a barrier or facilitator to receiving vaccines
Adolescent Vaccines HPV vaccine is offered as an adolescent vaccine or along with other adolescent vaccines (Meningitis or Tdap)
• 11 yr. old vaccine
• 12 yr. old vaccine
• Meningitis
Prevent Cancer Reason for getting HPV vaccine is cancer prevention
Protect HPV vaccine is seen as protection against cancer or genital warts
Recommendation • Offer vaccine during current office visit
• Recommend vaccine during current office visit
Relationship Building a relationship with patient aids in HPV vaccination
Reminders • Calls
• Postcard
• Text Message
Sexual Activity HPV vaccine is associated with sexual activity
Shot Records Clinic checks shot records to determine what vaccines patient is eligible for during visit
Standing Orders Clinic has standing orders for vaccines, may or may not include HPV
Well Visit HPV vaccine is talked about, offered or given during well visit
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Table 2
What Louisiana Healthcare Providers are Saying
Theme Quote
Education “We start educating parents then on what HPV is. I always give them the statistics on the amount of our the 
population estimated to already have HPV and not even be aware of it because it is typically asymptomatic 
so the parents are just very receptive…” (Interview 7)
Standing Orders “We do have standing orders and yes it includes HPV vaccinations and all the vaccinations that we give.” 
(Interview 1)
Reminders “…we have a pamphlet about how they can sign up for text messaging… we give a reminder call about all of 
our appointments the day before so we try to remind them to come in and then we send out patient reminders 
to go through the LINKS system.” (Interview 12)
“…we have what is called Televox and what it does is call the home and gives them friendly reminders of 
their appointment and we usually do it two or three days ahead of the appointment time… Then we have 
Televox give them an appointment for the next time and we have Televox to remind them of the 
appointment. So the Televox will call them and let them know that they have an appointment on whatever 
day it is and there it is located.” (Interview 6)
Appointments “We would also schedule the next visit at the current visit and that really helps with completion…” 
(Interview 3)
Protects Against Cancer “I let them know that it protects them against the cervical, oral, and anal cancers and that it takes all three 
(shots)…” (Interview 1)
Group with Other Vaccines “…we just grouped into the 11 year old vaccine with tetanus and meningitis vaccine.” (Interview 3)
Include in Well Visit as Well as 
Any Other Visit
“We try to make sure that they are up to date on their wellness visits and when they do come in for their 
wellness visits their shot records are reviewed as well as when they come in for other office visits.” 
(Interview 10)
Make the Recommendation “We start offering it when they come in for their 11 year old visits and most of them pretty much say that 
they will get it but each visit they come in and we see that they don’t have the Gardasil, then we offer it to 
them again and ask them if they have any questions and have the doctors back us up to try to get them 
vaccinated…” (Interivew 12)
Make the Recommendation “We go over their shot records pretty much every visit. Whether they come in sick or well or whatever, we 
try to keep up with them. We have thousands of kids linked here so it’s very difficult. We try to make sure 
that they are up to date on their wellness visits and when they do come in for their wellness visits, their shot 
records are reviewed as well as when they come in for other office visits. If we see that they are past due for 
shots, even if they are sick and can’t give them, we tell then to schedule an appointment in 7–10 days for a 
recheck and possibly to get their shots.” (Interview 10)
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